{"nctId":"NCT01875159","briefTitle":"Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm","startDateStruct":{"date":"2010-07"},"conditions":["Hypoxia"],"count":98,"armGroups":[{"label":"Caffeine","type":"EXPERIMENTAL","interventionNames":["Drug: Caffeine citrate 6 mg/kg/day"]},{"label":"Active Comparator: no caffeine","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Caffeine citrate 6 mg/kg/day","otherNames":["Cafcit"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Gestational age of 25 + 0 to 32 + 0 weeks PMA at birth, and 34 + 0 to 375 + 6 weeks PMA at randomization\n2. Prior treatment with caffeine based on routine clinical indications, and clinical caffeine now discontinued â‰¥5 days before randomization\n3. Previously tolerated clinical treatment with caffeine\n4. Breathing room air (no current supplemental O2 treatment; may have previously required respiratory support)\n5. Parental consent to enroll in pilot study\n\nExclusion Criteria:\n\n1. Congenital syndrome or other medical diagnosis associated with known risk for neurodevelopmental abnormality, including intraventricular hemorrhage Grade 3 or greater, cyanotic congenital heart disease, confirmed central nervous system infection, or fetal alcohol syndrome\n2. Currently receiving supplemental oxygen, ventilatory support, or nasal airflow therapy\n3. Clinical decision to restart caffeine prior to completing 5 days of continuous physiologic monitoring after clinical caffeine stopped\n4. Anticipated inability to meet protocol requirements","healthyVolunteers":false,"sex":"ALL","minimumAge":"33 Weeks","maximumAge":"37 Weeks","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Episodes of Intermittent Hypoxia Per Hour","description":"Number of episodes of Intermittent hypoxia per hour of pulse oximeter recording less than 90% oxygen saturation","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":"4.3"},{"groupId":"OG001","value":"8.4","spread":"8.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":"4.5"},{"groupId":"OG001","value":"8.2","spread":"11.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3","spread":"5.9"},{"groupId":"OG001","value":"5.2","spread":"6.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":"5.7"},{"groupId":"OG001","value":"4.7","spread":"6.1"}]}]}]},{"type":"PRIMARY","title":"Number of Seconds of Intermittent Hypoxia Per Hour","description":"Number of seconds of Intermittent hypoxia per hour of pulse oximeter recording less than 90% oxygen saturation","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50.9","spread":"48.1"},{"groupId":"OG001","value":"106.3","spread":"89.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.5","spread":"52.1"},{"groupId":"OG001","value":"100.1","spread":"114.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"58.8","spread":"74.1"},{"groupId":"OG001","value":"66.8","spread":"75.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.3","spread":"108.8"},{"groupId":"OG001","value":"66.0","spread":"74.8"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":42},"commonTop":["Tachycardia"]}}}